Losing access to these medications would also be catastrophic for many patients with chronic illnesses such as ME/CFS, cancer, Lyme disease, anemia, multiple sclerosis, Crohns disease, and CIRS who have come to depend on these substances for quality of life and disease management
AOD-9604 Oral vs Injection: Routes and Evidence AOD-9604 has been studied through more than one route, but doses cannot be directly converted between oral, intravenous, topical, nasal, and subcutaneous forms
1-10 mg/kg in animal studies Combined formulations: Ratios vary widely across research suppliers (5-50mg GHK-Cu, 5-10mg BPC-157, 5-10mg TB-500) Important: These are experimental doses used in animal studies and cannot be extrapolated to other species due to significant differences in metabolism, receptor density, pharmacokinetics, and peptide degradation rates
As endogenous pools of glutathione have been estimated to be ~10 mM in E
Food and Drug Administration for the treatment of HIV infection 172
The four other suppliers listed below offer the same glow stack peptide compounds at different prices and through different access points
